Nevertheless, when combined with the other standard clinical parameters including patients’ PSA and PSA density, BIA test provided meaningful information for discerning between PCa and BPH patients with an accuracy as high as 75% at a single patient level. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.